KIT D820Y
|
GIST
|
KIT D820Y
|
GIST
|
imatinib Sensitive: C3 – Early Trials
|
imatinib Sensitive: C3 – Early Trials
|
KIT D820Y
|
Thymic Carcinoma
|
KIT D820Y
|
Thymic Carcinoma
|
sorafenib Sensitive: C4 – Case Studies
|
sorafenib Sensitive: C4 – Case Studies
|
KIT D820Y
|
Melanoma
|
KIT D820Y
|
Melanoma
|
sunitinib Sensitive: D – Preclinical
|
sunitinib Sensitive: D – Preclinical
|